2022
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India
Du Z, Wang L, Pandey A, Lim WW, Chinazzi M, Piontti APY, Lau EHY, Wu P, Malani A, Cobey S, Cowling BJ. Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nature Medicine 2022, 28: 934-938. PMID: 35210596, PMCID: PMC9117137, DOI: 10.1038/s41591-022-01736-z.Peer-Reviewed Original ResearchConceptsLarge-scale survey dataEconomic benefitsFull dose vaccinationSurvey dataHospital admission costsDose-sparing strategiesCost of hospitalizationCOVID-19 deathsPopulation-level transmissionVaccine dosesVaccination strategiesAdmission costsEconomic burdenVaccine shortageFractional dosesVaccinationDose fractionationHigh transmissibilityVaccine distributionCostPublic healthVaccineWillingnessDosesIndia
2021
Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach
Kim D, Pekgün P, Yildirim İ, Keskinocak P. Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach. Vaccine 2021, 39: 6876-6882. PMID: 34688498, PMCID: PMC8520874, DOI: 10.1016/j.vaccine.2021.10.025.Peer-Reviewed Original ResearchConceptsInfection attack rateVaccine typesDifferent vaccine typesResource-limited countriesHigh-efficacy vaccinesDifferent study parametersVaccine shortageEfficacy vaccineHealth outcomesLife-saving vaccinesVaccineVaccine distributionLow efficacyAttack rateStudy parametersEfficacyHigh efficacyCOVID-19COVID-19 pandemicDeceased (SIRD) modelDifferent resource allocation decisionsLimited access
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply